INNVENTURE, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INNVENTURE, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $13.85M, a 14958.70% increase year-over-year.
- INNVENTURE, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $37.21M, a 3896.46% increase year-over-year.
- INNVENTURE, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $3.10M, a 1.53% decline year-over-year.
- INNVENTURE, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $92.00K, a 96.77% decline year-over-year.
- INNVENTURE, INC. stock issued during period, value, new issues for fiscal 2025 was $10.12M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $13.85M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $37.21M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $10.12M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $3.10M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $92.00K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $931.00K 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $3.14M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $2.85M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $7.57M 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Origin Investment Corp I (ORIQ) | $0.090B | 13.93 | |
| CO2 Energy Transition Corp. (NOEM) | United States | $0.040B | |
| Aimei Health Technology Co., Ltd. (AFJK) | United States | $0.038B | |
| Israel Acquisitions Corp (ISRL) | United States | $0.032B | |
| XFLH Capital Corp (XFLH) | United States | $0.139B | |
| Aldel Financial II Inc. (ALDF) | United States | $0.323B |